Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.
The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.
Kelland
N F
NF
Webb
D J
DJ
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D065130:Endothelin A Receptor Antagonists; D019332:Endothelin-1 / Q000502:physiology; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D011643:Publishing
D000959:Antihypertensive Agents; D065130:Endothelin A Receptor Antagonists; D019332:Endothelin-1